Segment disclosures

Company overview

RALLYBIO CORPORATION

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 19 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rlyb:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-31858000 USD20260316Open filing evidence
2024-01-01 – 2024-12-31636000 USD20260316Open filing evidence

Reporting Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=rlyb:ReportingSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD20261027Open filing evidence
2026-01-01 – 2026-09-30212000 USD20261027Open filing evidence
2026-04-01 – 2026-06-300 USD20260806Open filing evidence
2026-01-01 – 2026-06-30212000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31212000 USD20260513Open filing evidence
2025-07-01 – 2025-09-30212000 USD20261027Open filing evidence
2025-01-01 – 2025-09-30636000 USD20261027Open filing evidence
2025-04-01 – 2025-06-30212000 USD20260806Open filing evidence
2025-01-01 – 2025-06-30424000 USD20260806Open filing evidence
2025-01-01 – 2025-03-31212000 USD20260513Open filing evidence
2024-01-01 – 2024-12-31636000 USD20250313Open filing evidence
2024-07-01 – 2024-09-30299000 USD20251106Open filing evidence
2024-01-01 – 2024-09-30598000 USD20251106Open filing evidence
2024-04-01 – 2024-06-30299000 USD20250807Open filing evidence
2024-01-01 – 2024-06-30299000 USD20250807Open filing evidence
2024-01-01 – 2024-03-310 USD20250508Open filing evidence
2023-01-01 – 2023-12-310 USD20250313Open filing evidence